Hope Cancer Resources

Assets in 2024 (Year End)
$535,363
Cash & Equivalents
46%
Property, Plant, & Equipment (net)
34%
Receivables (Non-Related)
11%
Prepaid Expenses
10%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$249,012
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$248,823
$244,450
-2%
Receivables (Non-Related)
-
$57,420
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$80,633
$50,964
-37%
Investments
$1,023
-
-
Property, Plant, & Equipment (net)
$228,544
$182,529
-20%
Other Assets
-
-
-
Total Assets
$559,023
$535,363
-4%
Liabilities
2023
2024
Change
Payables & Accruals
$264,580
$249,012
-6%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$264,580
$249,012
-6%
Net assets
2023
2024
Change
Restricted Net Assets
$18,998
$3,063
-84%
Unrestricted Net Assets
$275,445
$283,288
+3%
Net assets
2023
2024
Change
Net assets
+$294,443
+$286,351
-3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)